The Global Health Technologies Coalition, the Council on Health Research for Development (COHRED), the International AIDS Vaccine Initiative (IAVI), and PATH released a new paper making the case for why research and development (R&D) for new and improved health technologies targeting the needs of low- and middle-income countries should be a critical component of the post-2015 development agenda.
The paper—The Role of Research and Innovation in the Post-2015 Development Agenda—builds upon the findings of The Lancet Commission on Investing in Health and existing literature by:
- Highlighting the ways in which R&D for health has contributed significantly to progress made towards the Millennium Development Goals (MDGs)
- Discussing the rationale for continuous prioritization of R&D for health in the post-2015 development agenda
- Providing preliminary suggestions for areas to consider as potential indicators of progress in global health R&D and innovation
While the paper details how past R&D investments have led to new health products which have driven significant progress toward achieving the health-related MDGs in the last decade, it also argues that current health technologies and levels of R&D investment are insufficient to overcome existing and emerging health threats and achieve the goals of the post-2015 agenda: poverty eradication and sustainable development.
As the global community continues to organize around these ambitious goals, the paper calls on key players to recognize the value of health improvements in ending poverty and the role that research and innovation for new health technologies plays in not only improving health outcomes, but also driving economic growth and progress in low- and middle-income countries. We hope you find this paper useful in your work, and ask that you continue to call on United Nations Secretary General Ban Ki-moon and Member States to include health R&D and innovation in the post-2015 agenda.